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Abstract- The Veterans Health Administration created in 2009 several Epilepsy Centers of Excellence (ECoE) for epilepsy 
treatment to improve health outcomes of veterans suffering undergoing treatment for epilepsy. Our outcomes study assesses 
the health quality at these ECoEs in comparison to non-ECoEs over a three year time period (2009 to 2011). Data from both 
ECoEs and Non-ECoEs were collected on a number of health outcome measures to empirically test if ECoEs led to better 
health outcomes than non-ECoEs. Findings show that ECoEs, compared to non-ECoEs, led to higher emergency room visits, 
higher hospitalizations, but lower drug prescriptions. However, ECoEs and non-ECoEs did not have statistically significant 
differences in adverse effects of medications. The study concludes with the findings, implications and limitations in ways that 
impact the prevailing perspectives on the concept of Centers of Excellence. 
General Terms- VHA (Veterans Health Administration; ECoE (Epilepsy Centers of Excellence). 
Keywords- Centers of Excellence; Outcomes Research; Healthcare Management; Focus in Action. 
1. INTRODUCTION 
Centers of excellence (CoEs) exist across the United States 
in a variety of disciplines, including business, technology, 
government, and medicine (Gunderman, 2006; Sugerman, 
2013).  While there is no universally acceptable definition 
of CoEs, there is wide agreement that CoEs lead to better 
outcomes relative to those that are not CoEs. That is, one 
can expect significant differences in some performance 
metric/s between CoEs and non-CoEs to merit the 
denomination of CoEs.  
CoEs particularly in healthcare attempt to develop 
methods to increase the efficacy of clinical procedures, 
decrease their risks, and improve patient outcomes. Thus, 
one expected positive output of CoEs in healthcare is the 
emergence of more efficacious clinical protocols for the 
rest of the healthcare industry (Hyer et al., 2009; 
McDermott et al., 2011). A CoE model, where hundreds of 
similar procedures are performed each year further, would 
provide economies of scale leading to experience-based 
learning and effectiveness. For example, several studies 
(Birkmeyer et al., 2003; Livingston, 2009; Latts & Singer, 
2010) found that, for most procedures, the mortality rate 
was higher among patients of low-volume surgeons than 
among those of high-volume surgeons, regardless of the 
surgical volume of the hospital in which they practiced.  
However, there are several arguments against CoEs. 
First, it is argued that the experience gained in CoEs is 
specific to their contexts and is not easily transferable to 
other contexts making the best practices developed in 
CoEs difficult to emulate. Second, the correlation between 
volume and patient outcomes may be clear but the 
extension requires crowding out other needed procedures 
at the healthcare institutions. Third, unless the criteria used 
to establish the CoEs are robust and validated, the benefits 
of a CoE program may not be realized. Fourth, CoEs are 
often demonized as competition-reducing entities that tend 
to force smaller and non-designated entities (let us call 
them non-CoEs) out of business (Wonderling et al., 2011; 
McClellan, 2011). Such market power by CoEs is often 
described as CoE-phobia in the healthcare marketplace 
(Levy, 2014). Finally, the expected benefits (for example, 
benefits of improved outcomes and cost-effectiveness) 
from CoEs must first be empirically validated rather than 
assumed. The rationale for our study stems from this last 
point about CoEs. Our study compares CoEs and Non-
CoEs in one particular setting to assess if CoEs excel their 
counterparts in health outcomes. 
The paper is structured in four sections. First, 
literature review is done on CoE concept leading to the 
research hypotheses and variables of the study. Second, the 
sample and data collection methods are described. Third, 
the results of data analysis are discussed. Fourth, the 
findings and limitations of the study are delineated. The 
paper concludes with several suggestions arising from 
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implications for future research, clinical practice and 
policy making.  
2. LITERATURE REVIEW 
Centers of excellence (CoE) are found in multiple 
areas, including IT, education, and health care. The three 
major justifying factors for CoEs include decreasing the 
costs, improving the quality, and improving customer 
satisfaction (America‘s SAP Users‘ Group [ASUG/SAP], 
2006). Centers of excellence (CoE) are a form of 
integrative health care involving the collaboration of 
multiple disciplines. In many respects, the theory of CoE is 
aligned with the expectation of lean process thinking 
theory. The overarching concepts of lean process thinking 
are standardization, eliminating excess, and process 
improvement (Lehman & Suozzi, 2008; Young & 
McClean, 2008; Joosten et al., 2009).  
Other health care theories emphasize the idea of 
multifactor determinants for changes in provision of health 
care. Weisbrod (1991) coined the phrase ―health care 
quadrilemma‖ to describe the integration of technology 
change, insurance, quality of care, and cost factors for the 
success of health care services (p. 523). CoEs are intended 
to provide focus in the complex healthcare environment 
(Grol et al., 2007). 
Using lean process thinking tools such as process 
reengineering, flow charting, Ohno‘s waste identification 
and reduction, lay-out planning, value stream mapping and 
other visuals that depict processes for delivering services 
(Bush, 2007; Shortell et al., 2007; Jooston et.al., 2009; 
Pronovost, 2011; O‘Malley, 2014)  in the ECoE program 
will be important in identifying the strengths and gaps. 
Comparing costs prior to the implementation of the ECoE 
and over the course of the initial three to four years of the 
program should also provide significant insight in the 
elimination of waste. In health care, lean process thinking 
success involves both operational and sociotechnical 
components (Joosten et al., 2009; Pronovost, 2011). 
In health care, many centers of excellence have been 
established by medical specialties (e.g., Shouldice Hospital 
in hernias) or a government entity such as the National 
Cancer Institute or the Veterans Health Administration or 
even a consumer products company such as Walmart who 
partnered with 6 nationally well-known health care 
organizations, including the Mayo Clinic and the 
Cleveland Clinic. Increasingly government is mandating 
the formation of CoEs to drive better outcomes. For 
example, in 2006, the Centers for Medicare & Medicaid 
Services ruled that Medicare would pay only for bariatric 
surgery that was performed at an ASMBS center of 
excellence or an ACS level 1 bariatric surgery center. In 
2012, the ACS and ASMBS decided to combine their 
certifications to create 1 set of national standards (CMS, 
2012). 
The National Association of Epilepsy Centers (1990) 
identified gaps in epilepsy care, such as access to care and 
substantial cost concerns. The National Institute of 
Medicine (NIH) initially funded ECoEs for the civilian 
health care sector. The VHA established similar centers as 
mandated by Veterans‘ Mental Health and other 
Improvements Act, P.L. 110-387 (2008). Physicians in 
multiple health care organizations struggle to improve 
access to care and maintain the quality of health care 
services within budget constraints and increased health 
care legislation reform leading significant differences in 
patient outcomes (Halpern et al., 2000; Fried & Gaydos, 
2002; World Health Organization [WHO], 2002; Nosek, 
2004; The Kaiser Foundation, 2008; Kasun, 2010; IOM, 
2012). The drive for CoE is aligned with the challenges 
faced by the national and global health care systems. 
The Centers for Disease Control (CDC) led multiple 
studies to develop quality care indicators for epilepsy care 
(Kobau et al., 2008). Effective quality metrics involve 
multipronged criteria that include measures of function and 
composition to produce objective data for evaluation 
(Koop et al., 2002). The Joint Commission (TJC), College 
of American Pathologists, and the International 
Organization of Standardization developed indicators and 
metrics for quality.  At a minimum, patient outcomes can 
be measured by what happens to the patient during and 
after medical interventions such as hospitalizations, # of 
medications or diagnostic assessments (Colvello & 
Merkhofer, 1993; Sperling et al., 1999; Palin et al., 2008). 
The Veterans Health Administration (VHA) 
The VHA, being one of the largest health care 
delivery systems, has evolved from predominately 
inpatient hospitalization and residential support from 1930 
until the early 1960s into a program of balance for both 
inpatients and outpatients, as a result of congressional 
activity such as P.L. 106-117 and the Veterans Millennium 
Healthcare and Benefits Act (1999); Shay & Yoshikawa, 
2010). Currently, the VHA consists of approximately 150 
medical centers, 130 nursing homes, 950 community-
based clinics, and 230 counseling centers distributed 
throughout 21 regional or Veterans Integrated Service 
Networks (VISN) (GAO 11-205, 2010); 5.6 million 
Veterans receive services from the VHA annually (Darkins 
et al., 2008). 
CoEs offer equity of superior-quality services, fiscal 
responsibility, support, guidance, sharing resources, and 
coordinated, collaborative governance toward a pursuit of 
excellence (DeMaria et al., 2010; George Mason 
University 2010; Khalil et al., 2001). Although the 
definition of COE varies in application, a common theme 
for COE is collaboration that offers synergistic 
performance. The VHA mandated ECoE to meet the 
demands of the projected increase of epilepsy in the 
Veteran population. The Veteran Mental Health and Other 
Care Improvements Act (Public Law [P.L.] 110-387, Title 
IV, Sec 404, 2008) mandated the establishment of the 
Epilepsy Center of Excellence (ECoE).  
3. RESEARCH QUESTIONS AND 
HYPOTHESES 
International Journal of Management Excellence 
Volume 4  No.3  February 2015 
 
©
TechMind Research, Society         531 | P a g e  
 The primary research question is: Do ECoEs 
excel in health outcomes for patients relative to non-
ECoEs? The ECoE provides a corralling of resources for 
epilepsy-specific health care; therefore, Veterans receiving 
care within the ECoE system should show significantly 
better results in quality, access, and cost factors than the 
Veterans receiving care at VA non-ECoE sites. 
Patient Outcomes    
Frequency of emergency room visits and 
hospitalizations, number and distribution of prescribed 
medications, and adverse side effects are expected to be 
significantly different between ECoE and non-ECoE sites. 
Research indicates that quality can be defined by correct 
diagnosis, the availability of testing as needed, medication 
control, minimum urgent medical visits or hospitalization, 
and appropriate patient education (Campbell et al., 2000; 
Lingsma, 2010; Manjunath et al., 2012).  
H01a:  There is no significant difference in frequency 
of emergency room visits between types of unit (non-
ECoE, ECoE). 
H01b:  There is no significant difference in frequency 
of hospitalizations between types of unit (non-ECoE, 
ECoE). 
Specific to epilepsy, quality of care is demonstrated in the 
number of medications prescribed and the control of side 
effects associated with AEDs (Begley et al., 2011; Pugh et 
al., 2011). Correct diagnosis is important for prescribing 
the right number medications and for providing 
appropriate individualized treatment plans (Stephen et al., 
1999; Kwan & Brodie, 2001). Therefore, it was expected 
that the non-ECoE unit patients would have significantly 
more prescribed drugs, less orders, and more abnormal lab 
results for calcium and Vitamin D testing (reflecting bone 
health) than the patients in an ECoE unit. 
H02: There is no significant difference in the number 
of prescribed medications between types of unit (non-
ECoE, ECoE). 
H03: There is no significant difference in adverse side 
effects related to long term use of AEDs, between 
types of unit (non-ECoE, ECoE). 
H03a: the measure is adverse effects per Vitamin D 
deficiencies 
H03b: the measure is adverse effects per Calcium 
deficiencies 
Population, Sample And Variables  
Population. The population for the study was the patients 
suffering from epilepsy in the VHA. Approximately 2 
million people are diagnosed with epilepsy in the United 
States (Centers for Disease Control, 2011). A national 
ECoE study estimated that the VHA had 87,377 patients 
with an epilepsy diagnosis, and 15,830 (18.1%) were 
enrolled in 16 ECoE facilities nationally.  
Sample. In this study, four ECoEs in South East were 
compared with ten VA non-ECoE centers. The 10 VHA 
medical centers not designated as ECoE sites were 
randomly selected from the population of all non-ECoEs. 
Randomization provides a better chance of capturing 
variety and increases the potential for a well-represented 
cohort of patients (Campbell & Swinscow, 2009). Data 
were collected from 4 ECoEs and 10 non-ECoEs 
designated as such by VHA.  
The historical data of seizure patients for the two cohorts 
of non-ECoE and ECoE units for consecutive VHA fiscal 
years from 2009 through 2011 (FY09, FY10, and FY11) 
were collected from the VHA VSSC databases, the main 
VHA database warehouse where all data for administration 
and operation is maintained. Using the Holden algorithm 
(Holden et al.,2005; Pugh et al., 2008), patients with at 
least one inpatient or outpatient seizure encounter (ICD-
09-CM 345.xx or 780.3x) and at least 30 days or more 
AED prescriptions in the same fiscal year were considered 
VA epileptic patients.  
Variables. Six variables were identified in this study, 
one independent variable and five dependent variables. 
The independent variable was a type of unit, and the 
dependent variables were frequency of emergency room 
visits and hospitalization episodes, number of prescribed 
medications, adverse side effects related to long-term use 
of AEDs,. 
Frequency of emergency room visits and 
hospitalizations.  These were determined by the number of 
encounters for hospitalizations and emergency room visits 
in the VSSC databases. 
Number of prescribed medications.  These were 
identified by the number of prescriptions for 30 epilepsy 
drugs in the pharmacy benefits package that is a part of the 
VSSC database (Pack & Morrell, 2004). 
Adverse side effects related to long-term use of AEDs.  
Evaluation looked specifically at the calcium and vitamin 
D lab results. From the laboratory section of the VSSC 
database, the number of orders for referenced tests and the 
number of abnormal calcium and vitamin D results were 
compared between the ECoE and non-ECoE units. 
4. DATA ANALYSIS AND RESULTS 
The study used Chi-squared and independent ‗t‘ test to 
determine significant differences between the ECoE and 
non-ECoE units. Comparative analyses drives the method 
and design selection of our research (Whittermore & 
Meikus, 2008; Creswell, 2009). The normality 
assumptions of ‗t‘ tests did not matter due to large sample 
size (Lumley et.al, 2002; Weaver, 2004; Campbell & 
Swinscow, 2009; Fay & Proschan, 2010). 
For first hypothesis (a, and b), ‗t‘ tests for significance of 
the difference between two independent means were 
conducted. The independent variable is the type of unit 
(non-ECoE, ECoE) and the dependent variables are 
frequency of emergency room visits and hospitalizations.  
The resulting two-tailed significance value is reported; if p 
< α = .05, the difference in the independent means is 
considered as a significant difference.  
For second and third hypotheses, chi-squared analyses 
were conducted. The independent variable was the same as 
stated above and the dependent variables were the number 
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of prescribed medications, adverse side effects related to 
long- term use of AEDs, and proportion of fee basis 
patients. Since chi-square tests are nonparametric, only 
two assumptions exist for their use, according to Field 
(2009): observations must be independent from each other, 
and the expected cell frequencies must be greater than five. 
The data analysis includes a table representing the cell 
frequencies as well as statistics representing the 
significance. For this analysis, alpha was set at p < .05. 
Findings 
Frequencies of ER visits. 
The average visits to the ER showed a downward trend 
across the three years of data collected. Therefore, the 
average visits were higher in FY09 baseline year than in 
FY11.  FY09 showed a statistically significant higher 
average number of visits for the ECoE unit. This 
significant difference between the units was also noted in 
the intervention year FY11and thus, H01a is rejected.
Table 1: Frequency of Emergency Room (ER) Visits 
Statistics FY09  FY10 FY11  
 ECoE Non-ECoE ECoE Non-ECoE ECoE Non-ECoE 
 Total patients 3571 5199 3515 5363 3183 4801 
Total # of visits 4642 5558 4479 6279 3915 4947 
Avg # of Visits 1.29 1.06 1.27 1.17 1.23 1.03 
t test               4.46 2.0              3.7 
df          8768   8876             7982 
p         <.0001   0.0459            .0002 
Hospitalization frequencies.  
The average hospitalizations for the ECoE unit were 
higher in FY09, FY10, and FY11. A statistically 
significant difference between the two units was noted in 
all the three years of data and is presented in Table 2. 
Significant difference in average hospitalizations between 
the units was noted in FY11 and thus, H01b is rejected.
Table 2: Frequency of Hospitalizations 
Statistics FY09  FY10 FY11  
 ECoE Non-ECoE ECoE Non-ECoE ECoE Non-ECoE 
Total patients 3571 5199 3515 5363 3183 4801 
Total # of visits 1986 2220 1798 2284 1558 1823 
Avg # of Visits .55 .43 .51 .43 .49 .38 
t test              5.14 3.56              4.31 
df                    8768   8876             7982 
p                      <.0001   0.0004            <.0001 
Medications prescribed 
Chi-squared statistical testing was used to evaluate the 
proportion of patients for three categories for the number 
of prescribed AEDs (1 AED prescription, 2 AED 
prescriptions, and 3 or more AED prescriptions). 
Results of χ2 test for distribution of prescribed medications 
are shown in Table 3. In the baseline year FY09 statistical 
significance was noted for the prescribed medications.  
However, no statistical significance was noted in FY10 or 
FY11 and thus the results accept H02 hypothesis
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Table 3:  Counts of Patients Prescribed AED Medications 
Number of medications FY09  FY10  FY11 
 ECoE Non-ECoE ECoE Non-ECoE ECoE Non-ECoE 
Total patients 3571 5199 3515 5363 3183 4801 
1 2264, 63.4 3406, 65.5 2225, 63.3 3430, 64.0 1996, 62.7 3026, 63.0 
2 971, 27.2 1373, 26.4 944, 26.9 1481, 27.6 873, 27.4 1354, 28.2 
3 or more 336, 9.1 420, 8.1 346, 9.8 452, 8.4 314, 9.9 421, 8.8 
χ2(1) a 6.2950 5.3239  2.9409      
P .0430         .0698          .2298            
Percentages may not equal 100 due to rounding. 
aDegrees of freedom for χ2 test. FY: fiscal year 
Adverse side effects due to long term uses of AEDs.   
Statistical significance was found in FY09 and FY10, the 
non-ECoE unit reported a higher proportion of abnormal 
Vitamin D results than the ECoE unit. No statistical 
difference found in the reporting of abnormal vitamin D 
results in the two units (non-ECoE, ECoE) for FY11 (see 
Table 4), thus evidence supports the rejection of the 
hypothesis (H03a) for Vitamin D results. 
Table 4:  Counts of Patients with Abnormal Vitamin D Lab Results 
 FY09  FY10  FY11 
Test results ECoE Non-ECoE ECoE Non-ECoE ECoE Non-ECoE 
Total patients 3571 5199 3515      5363    3183 4801 
Abnormal 47, 46.1% 79, 63.7% 65, 45.1% 124, 59.3% 94, 42.3% 123, 51.0% 
Normal 55, 53.9% 45, 36.3% 79, 54.9% 85, 40.67% 128, 57.7% 118, 48.9% 
χ2(1) a 7.0522 6.9027  3.5083  
P .0079         .0086          .0611      
Percentages may not equal 100 due to rounding. 
a.Degrees of freedom for χ2 test. FY: fiscal year 
Calcium.  Calcium tests are often performed in routine 
blood workup because irregular levels (rarely present as 
visibly problematic) can be an indication of many medical 
issues (Pack, 2005; Wysolmerski & Insogna, 2011). For 
calcium testing, the proportions of abnormal results were 
not found to be statistically different between the two units 
(Table 5) in FY 09 or FY11. Therefore the H03b 
hypothesis is accepted for Calcium results.
Table 5: Counts of Patients with Abnormal Calcium Lab Results 
 FY09  FY10  FY11 
Test results ECoE Non- 
ECoE 
ECoE Non- 
ECoE 
ECoE Non-ECoE 
Total patients 3571 5199 3515 5363 3183 4801 
Abnormal, % 162, 19.5 297, 20.2 137, 16.37 305, 19.99 136, 17.7 222, 17.0 
Normal, % 668, 80.5 1174, 79.8   700, 83.6 1221, 80.01 631, 82.3 1082, 82.9 
χ2(1) a          .1502      4.6553  .1688  
P          .6984               .031         .6812          
Percentages may not equal 100 due to rounding. 
aDegrees of freedom for χ2 test. FY: fiscal year 
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5. DISCUSSION 
The general theoretical concept of the CoE is to 
improve quality of outcomes, increased access, decreased 
costs, and sustainability of improvements (Nilsson et al., 
1999; Lehman & Suozzi, 2008; So et al., 2009).   
Comparison of hospitalization in ECoE and non ECoE 
units. The results for hospitalization frequencies were also 
found to be statistically significant in both years with the 
ECoE unit demonstrating a higher incidence of 
hospitalization than the non- ECoE (Table 2). Given the 
amount of required hospitalizations for Long Term 
Monitoring (LTM) of EEG testing, an increased number of 
hospitalizations in the ECoE unit when compared to a non-
ECoE would be a reasonable finding. 
The availability of LTM only in the ECoE unit, and 
the assertion that the ECoE unit cohort includes sicker 
patients are extraneous variables that may influence the 
frequency of hospitalizations and ER visits and affect the 
comparative evaluation of the units. The discovery of the 
extraneous variables also justified the decision to evaluate 
frequency of ER visits and hospitalizations separately. 
Medication prescription patterns. The number of 
epilepsy medications prescribed for patients were 
compared using categorical data.  Prior research indicates 
that approximately 60% of epileptic patients are controlled 
with one prescribed drug (Brodie, 2001).  However, the 
comparative data results between the ECoE and non-ECoE 
units were not statistically different (Table 3). 
Interventions take time to implement, and 
determination of impact via evaluation can be time 
sensitive in accordance with complete implementation. 
There is evidence that the ECoEs intervention was not 
fully completed implemented in FY11; therefore, the lack 
of difference in the two types of units  may be attributed to 
a premature evaluation of this variable.  
Quality maintenance in laboratory tests 
For the last quality variable, our study examined lab 
results. Research has confirmed the correlation of AEDs 
and bone health; therefore, management of Vitamin D and 
calcium results is important (Pack, 2005). The Vitamin D 
blood test is more specific for bone health, while calcium 
blood testing is done frequently for general health care 
evaluations. 
The adverse side effects of AEDs were measured 
through abnormal lab results for calcium and Vitamin D 
levels. No significant differences were found in the 
baseline year or in FY11 among units for calcium results. 
However, FY09 had shown a significant difference where 
the non-ECoE unit data contained a larger percentage of 
abnormal vitamin D results than the ECoE unit.  In FY11, 
the percentage of abnormal results decreased in both units 
and no significant difference was found.  
Policy Implications 
This project has the potential to result in policy 
implications for higher utilization of ECoEs and 
implementation of CoEs for other health care 
subspecialties in the VHA and more wide-spread use of 
CoEs by other health care entities (Wechsler, 2007). Prior 
to the establishment of ECoE, specialized epilepsy 
healthcare was diverted to external (non-VA) providers 
when resources were unavailable. PL 110-387 made 
provisions for funding to enhance resources within the VA. 
Without CoEs, the specialized care can be fractured 
(Strzelczyk et al., 2008).  
If future evaluations of the ECoE program reaffirm the 
findings from this study, the VHA ECoE leadership should 
consider policies that increase the number of ECoEs, 
distribute the ECoEs more evenly across the nation, and 
approve nontraditional operations to address an expected 
increase in  ER visits and higher mean cost when fee- 
based service becomes necessary.   
Recommendations for Future Research 
Our study focused on five specific direct variables for 
the factors of quality. Future research should consider 
other co-variants such as access and cost and others that 
may affect quality of care (Salinksy et al., 2011).  Future 
research should also evaluate referral patterns between 
ECoE units and non-ECoE units; examine or track 
consultations and formal communication modes between 
ECoE providers and non-ECoE providers. Additionally, 
time lapse between the implementation of intervention and 
between evaluations should be carefully considered for 
future studies of medical CoEs, as this may vary and be 
dependent on the specifics of the diagnosis or condition 
being assessed. 
Given our empirical findings, future studies should 
also examine whether the concept of Centers of Excellence 
is more applicable to surgical COEs (e.g., hernia 
operations at Shouldice Hospital in Toronto) rather than 
medical CoEs (e.g., Epilepsy CoEs as in our study). Future 
research should also adjust for the effects of patient 
characteristics that may vary across CoEs and non-CoEs. It 
is quite possible that sicker patients may be going to CoEs 
which will effect patient outcomes. Risk adjustment is 
particularly important for outcome measures because 
patient outcomes are driven not just by quality of care but 
also by age, gender, medical history, comorbidities, 
behavioral and social factors, and physiological factors. 
Limitations and Strengths of the Study 
One limitation of our study is that we have not 
adjusted for confounding variables such as patient age, 
sex, education, comorbidities and complications in 
examining differences in patient outcomes. At a minimum; 
ideally one must also consider whether patients have drug 
resistant epilepsy or not, etc.) before definitive conclusions 
can be reached regarding whether Centers of Excellence 
excel in patient outcomes. Our defense of our study lies in 
the large sample size of our study (n=8770), and that we 
are making overall inferential assessments at institutinal 
levels for CoEs vs. non-CoEs. However, we agree that 
future studies should examine the confounding variables 
when studying patient outcomes. 
To the best of our knowledge, this is the first 
quantitative analysis project of its kind in ECoEs.  The 
strength of the study lies in the use of a previously 
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validated algorithm for data extractions from one of the 
most extensive databases in the country. The VHA is 
world renowned for its databases, and with proper 
clearance, readily accessible national information.  
The algorithm used to identify epilepsy patients was 
previously validated for the geriatric veteran population 
(Pugh et al., 2008). However, for general VHA patients the 
validation research is still underway and the validity of the 
algorithm for other populations is not fully established. 
Use of new AED medications for conditions other than 
epilepsy may have led to false positives. Covariates, such 
as homeless patterns and family support systems, were not 
included in this study, and these could influence quality 
results. Additionally, referral patterns and movement 
between parent stations due to resident relocations were 
not considered in this study. Although the P.L. mandated 
the program in 2008, and implementation was expected in 
2009, new information acquired during the course of the 
study confirmed that gaps in workload captured existed 
through 2011, or that some portions of the intervention 
were not completed implemented at that time.  Since 
implementation is not fully complete, an evaluation of this 
caliber at this time may be perceived as premature. With 
full implementation of the ECoE, results could change. 
Complete workload capture is necessary for a more 
reliable and comprehensive evaluation. 
6. CONCLUSION 
This study specifically evaluated the CoE intervention 
for specialized epilepsy care in the VHA. The potential 
that VHA ECoE practices are exportable for other CoE 
models is in alignment with Congress‘ support of the VHA 
mission to provide quality care to veterans; the ECoE was 
designed to meet the needs of veterans plagued with 
seizures. Thus, valid studies of the efficiency of CoE 
medical models can be expected to have strong 
implications for future medical business acumen and 
quality health care services. 
In the short time the PL 110-387 (2008) has been in 
effect, the VHA has responded remarkably to maximize 
specialized resources by establishing ECoEs to provide 
quality epilepsy healthcare for Veterans. The VHA ECoE 
program is essential for veterans ―who have borne the 
battle,‖  and modern warfare increasingly exposes troops 
to dangers of TBI and PTSD (Nilsson et al., 1999; 
Raymont et al., 2010).  CDC (2011) reports that10% of 
Americans will experience seizures and 3% will be 
diagnosed with epilepsy prior to age 80.  These statistics 
further justify the need for appropriate specialized care for 
epilepsy and seizure symptoms. 
The CoE concept suggests that the benefits from CoE 
are not limited to those realized at the CoE entity level but 
extend to the creation of better protocols (processes) for 
dissemination to other nonCoEs. Such additional benefits 
from CoEs are not considered in our study but must be 
reckoned with when assessing CoEs which must be viewed 
as investments for social good. 
Lastly,  CoE concept must be implemented more 
cautiously for its benefits to become manifest in the 
healthcare arena. In the complex healthcare environment, 
realization of economies of scale and quality 
improvements through CoE concept implementation may 
be easier said than achieved as our study findings 
demonstrate. 
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